at Zacks.com (Jan 20, 2015)
Henry Schein (HSIC -7.4%) beat Q3 estimates, but earnings climbed less-than-expected as the vaccine maker suffered from lower sales of its flu shots and margin pressure due to higher costs. The company also issues cautious guidance for FY12, citing foreign currency concerns.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Jan 15, 2015)
at Zacks.com (Jan 8, 2015)
at Nasdaq.com (Dec 31, 2014)
at Zacks.com (Dec 26, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs